Blood Transfusions
last authored:
last reviewed:
Introduction
Unit = 450 ml plus 50 ml anti-coagulation
return to top
Types of Blood Products
- pRBC
- platelets
- fresh frozen plasma
- cryoprecipitate
- albumin
- immunoglobulins
RBC transfusion
Used in amenia, though there is no absolute number to determine when, or when not, transfusions are required. It is rarely necessary if Hg is greater than 90 g/L and is often necessary if it is under 60 g/L.
When to Use?
Everyone agrees these days that no or less blood is a great thing.
Consider:
- severity and rapidity of anemia
- potential to correct/control cause (ie, EPO, iron, vitamins)
- presence of cardiovascular disease
For total hip replacements, the rates of people receiving blood have gone from 75% to 10%.
This is due to:
- a lowered threshold of transfusion
- improved attention to surgical hemostasis
- autologous blood donation (less done these days)
- must be done within 35 days
- acute normovolemic hemodilution
- autologous donation done before surgery
- saline administered as fluid replacement, so blood loss is of diluted blood
- blood reinfused following surgery
- blood substitutes
- volume expanders: pentaspan
- red blood cells: fluorocarbons, cross-linked hemoglobin preparations
- blood salvage devices
- cell savers
- storage of blood lost to fixed space
- blood is reinfused after hemodilution and clotting factor depletion
- drugs:
- EPO
- DDAVP: mild/moderate VWB, hemophilia, platelet function disorders
- antifibrinolytics: reduces blood loss during cardiac surgery
A RCT comparing 30 day mortality in the two groups: maintenance of HgB at 70-90g/L, versus 100-120 g/L in an intensive care unit, found that more is not necessarily better. Physicians are now much more conservative.
Platelet transfusion
Used in thromobocytopenia if:
- less than 10x109/L any time
- less than 50x109/L for surgery or during active bleeding
- less than 100x109/L for neurosurgery
Plasma transfusions
Fresh frozen plasma (FFP) contains 100% of all clotting factors
Frozen plasma contains all factors except VIII (perhaps 50%)
Use plasma transfusions in:
- massively bleeding patients
- coagulopathy in actively bleeding patient
- preoperatively in patients with coagulopathy not responsive to vitamin K (ie due to liver disease)
Cryoprecipitate
- Von Willibrand's factor (factor VIII)
- fibrinogen
Albumin
provides volume and oncotic support in situations of:
- hypovolemic shock
- burns
- cardiopulmonary bypass
a 5% solution is iso-oncotic with normal plasma, while a 25% solution is hyperoncotic
an alternative is crystalloid or pentaspan
Immunoglobulin preparations
High concentrations of antibodies used in immunodeficiency or autoimmune disorders. These are non-specific, pooled from many donors.
Some preparations have antibody specificity
- anti-D
- anti-CMV
- anti-Hepatitis B
return to top
Safety of Donated Blood
Donor screening
Face-to-face interview to identify risk factors
Confidential donor exclusion is done. There is a tremendous amount of concern about confidentiality, and so people have the option to "donate" blood and self-select out if they know they should not donate but don't want people to know.
Blood Screening
- HIV 1 and 2
- HTLV
- Hepatitis B and C
- syphilis
- cytomegalovirus
- West Nile Virus
Leukodepletion
WBCs can carry certain pathogens and so are removed at site of donation. This also reduces the chance of febrile tranfusion reactions, as well as the risk of immunomodulation (host infections, cancer) due to changes in the host's immune system.
Manufactured blood products are treated like any other commercial products, with additional safety steps including:
- screening for viruses
- treated to eliminate bacterial infection and enveloped viruses
- purification into components
return to top
Risks of Transfusion
informed choice is important in transfusion.
Canadian Transfusion Safety Officers offer advice.
Common Infections
- HIV: less than 1 per 4,000,000 units
- Hepatitis B: less than 1 per 275,000 units
- Hepatitis C: less than 1 per 3,000,000 units
- bacterial: 1 per 500,000 units of RBCs; 1 per 2,000 platelets
Non-infectious blood reactions
Reactions
Patient identification is by far the most important factor.
- acute hemolytic reactions
- transfusion-related lung injury
Acute Hemolytic Reactions
Acute hemolytic reactions occur following the rapid destruction of donor cells by the recipient's antibodies, leading to massive intravascular hemolysis. Disseminated intravascular coagulation, renal failure, shock, and death can occur. Reactions of this nature are usually due to ABO incompatability, though can also be mediated by other alloantibodies. Clerical or procedural error is the usual cause.
Presentation
Patients may present with:
- fever
- flank pain
- brown or red urine
- shock
Treatment
Rapid, life-saving treatment is mandated:
- stop the transfusion
- provide oxygen
- fluid resuscitation
- bloodwork for CBC, electrolytes, creatinine, cross and type, coagulation
- dialysis if hyperkalemia appears to be life-threatening
transfusion related lung injury: 1/5,000
- anti-host WBC antibody mediated
- acute SOB due to fluid infiltration
- can be life threatening, requiring several days of intubation
- transient, with usual complete recovery
Most common cause of fever is reaction to minor WBC antigens.
- acute hemolytic reaction:
- delayed hemolytic reaction: 1/5,200
- up to 5-10 days later
- subclinically sensitized to RBCs; spleen takes them out
- allergic reaction: 1/33
- anaphylatic reaction: 1/20,000
- febrile non-hemolytic transfusion reaction: 1/71 (0-6 hours)
- usually in response to antigen on donor lymphocytes
- circulatory overload: 1/100
- especially in people with cardiac problems
- citrate toxicity - can chelate
- hyperkalemia
- hemorrhagic state due to dilutional coagulopathy
- iron overload: treat with
Transfusion-Related Lung Injury
Complications of massive transfusions
- trali
- ards
- volume overload
- dilotional coagulopathy
- DIC
- Hypocalcemia
- metabolic alkalosis (from citrate)
- hypokalemia
- hypothermia (products are in cold storage)
return to top
Hospital Related Safety Issues
Proper patient identification - by far the most important way to avoid adverse reactions.
- collection of crossmatch
- infusion of blood
Informed consent
- benefits and risks
- alternatives
- documentation of the process
Notification regarding transfusion
Refusal of transfusion
Resources and References
return to top